Valuation: Stereotaxis, Inc.

Market Cap 120M 107M 99.88M 91.01M 171M 11.58B 174M 1.21B 468M 5.9B 451M 442M 18.94B P/E 2026 *
-5.9x
P/E 2027 * -8.18x
Enterprise Value 120M 107M 99.88M 91.01M 171M 11.58B 174M 1.21B 468M 5.9B 451M 442M 18.94B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 2.63x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
1 week-6.98%
Current month-2.44%
1 month-12.41%
3 months-32.20%
6 months-35.14%
Current year-47.83%
1 week 1.18
Extreme 1.175
1.32
1 month 1.18
Extreme 1.175
1.42
Current year 1.18
Extreme 1.175
2.86
1 year 1.18
Extreme 1.175
3.59
3 years 1.18
Extreme 1.175
3.59
5 years 1.18
Extreme 1.175
7.22
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-6.98%-61.78%-24.05% 123M
-3.34%-3.81%+22.95%+28.91% 250B
-4.42%-5.37%-0.53%-14.65% 156B
-1.33%+0.43%-8.40%+37.27% 144B
-0.96%-3.25%-54.90%-18.12% 63.26B
-1.31%-0.63%+11.64%+22.96% 49.75B
-3.27%-3.56%+20.28%+49.06% 48.58B
-0.95%+1.07%-18.77%-21.65% 47.99B
-1.23%+2.58%-3.86%+38.57% 46.22B
-3.15%-1.11%+33.06%+55.18% 43.17B
Average -2.24%-0.81%-6.03%+15.35% 84.81B
Weighted average by Cap. -2.64%+0.45%+3.38%+18.62%

Financials

2026 *2027 *
Net sales 34.33M 30.49M 28.52M 25.99M 48.93M 3.31B 49.6M 345M 134M 1.68B 129M 126M 5.41B 45.67M 40.56M 37.93M 34.57M 65.08M 4.4B 65.97M 459M 178M 2.24B 171M 168M 7.19B
Net income -20.13M -17.88M -16.72M -15.24M -28.69M -1.94B -29.08M -202M -78.32M -987M -75.59M -73.95M -3.17B -14.77M -13.12M -12.27M -11.18M -21.04M -1.42B -21.33M -148M -57.44M -724M -55.44M -54.24M -2.33B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
01/10/26 $1.200 -2.44% 671,545
30/09/26 $1.230 -1.60% 336,997
29/09/26 $1.250 -0.79% 710,824
28/09/26 $1.260 -3.08% 493,072
25/09/26 $1.300 +0.78% 405,561
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.200USD
Average target price
3.000USD
Spread / Average Target
+150.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock